Global Ferritin Testing Market

Global Ferritin Testing Market Size Insights Forecasts to 2035

• The Global Ferritin Testing Market Size Was Estimated at USD 975.66 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.35% from 2025 to 2035
• The Worldwide Ferritin Testing Market Size is Expected to Reach USD 2127.75 Million by 2035
• Europe is expected to Grow the fastest during the forecast period.

According to a Research Report Published by Decisions Advisors and Consulting, The Global Ferritin Testing Market Size was worth around USD 975.66 Million in 2024 and is predicted to Grow to around USD 2127.75 Million by 2035 with a compound annual growth rate (CAGR) of 7.35% from 2025 to 2035. The rising integration of ferritin biomarkers into customised nutrition platforms is driving the global market's steady rise, which is particularly fueling the need for diagnostics globally. The demand for ferritin testing has been fueled by the growing incidence of iron overload conditions, such as hemochromatosis and iron deficiency anaemia.

 

Market Overview

The ferritin testing market is the collective name for industries across the world that are using various tests and diagnostic tools to measure the level of ferritin in your blood (serum, plasma or whole blood) to determine how much of your body's iron stores, as well as any disorders related to low iron levels including: angle of anemia, angle of hemochromatosis, angle of chronic kidney disease, angle of iron deficiency associated with pregnancy. Hospitals, diagnostic labs and preventive healthcare providers are included in this global marketplace for products like lab instruments, laboratory reagents & kits, and assays (including ELISA, CLIA, etc.). Iron deficiency and iron overload are common clinical and public health problems. Iron deficiency may give rise to anaemia, tiredness, lack of energy, stunted development in children, lowered physical exercise performance, and, quite often, it may indicate a serious underlying disease. Iron overload disorders may be primary or classic haemochromatosis or secondary haemochromatosis, which result in liver, heart and hormonal diseases such as diabetes. In each case, correct identification is necessary in order to properly clinically and health-wise guide public solutions. Immediate diagnosis is necessary so that the correct course of treatment can be started without delay and thus prevent further accumulation of iron in the body. Adoption is being driven by the expanding usage of ferritin assays in hospitals and diagnostic labs, the growing need for preventative healthcare, and improvements in diagnostic technologies.

 

According to the WHO's estimations, it has been shown that globally at least 40% of pregnant women and 42% of all children under 5 years of age are identified as being anaemic. Three of the most common causes of anaemia are iron deficiency, haemoglobinopathies, and malaria globally. WHO recently developed updated guidelines to diagnose iron deficiency and overload with improved specificity using modified ferritin levels, which were developed using WHO's systematic method of developing Evidence-Informed Guidelines for anaemia.

 

Report Coverage

This research report categorises the ferritin testing market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the ferritin testing market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the ferritin testing market.     

 

Driving Factors  

The growing awareness of the importance of monitoring iron levels during pregnancy, among chronically ill and pediatric patients, has led to an increased demand for ferritin testing. Innovations in diagnostic technology (like the development of automated analysers and point-of-care (POC) testing kits) have made ferritin tests easier to access and more accurate than ever before. Furthermore, as the healthcare sector focuses more on prevention than on treating disease, the growth of the healthcare infrastructure within emerging economies has increased the use of ferritin tests for early diagnosis and optimal management of patients. The latest technological developments in ferritin testing include the creation of POC devices that allow for quick testing of blood samples. Examples of these devices include microfluidic paper analytical devices (µPADs) and paper-based electrochemical immunosensors. Opportunities in the ferritin testing sector have also been brought about by the growing demand for wellness programs and preventive healthcare. Regular screening for iron levels as part of regular health examinations is becoming increasingly popular as people become more conscious of their health.

 

The WHO guideline in 2020 provides global recommendations on using ferritin concentrations to assess iron status in both individuals and populations. It establishes ferritin as the primary biomarker for iron storage, guiding clinical diagnosis of iron deficiency and public health monitoring of anaemia and iron interventions.

 

Restraining Factors  

The ferritin testing marketplace is limited by the decrease in diagnostic specificity due to histological factors resulting from the chronic phase reactant characteristic of ferritin. They are limiting the capabilities of precisely identifying the presence of iron-deficient disorders, including iron deficiency with anaemia. Thus, the clinician must use various additional biomarkers for diagnosis and provide complexity in determining the diagnosis.

 

Market Segmentation    

The ferritin testing market share is classified into product, and application.     

• The reagent segment dominated the market in 2024 and is projected to grow at a significant CAGR during the forecast period.        

Based on the product, the ferritin testing market is divided into instrument, reagent, kits, and others. Among these, the reagent segment dominated the market in 2024 and is projected to grow at a significant CAGR during the forecast period. The increasing development of micro-volume ferritin reagent formulations optimised for low sample biochemistry systems is the driving force behind this growth. Such formulations allow laboratories to perform high-accuracy ferritin testing even with minimal blood volumes, which is advantageous for neonatal, pediatric, and geriatric diagnostics.

 

• The anaemia segment accounted for the highest share in 2024 and is projected to grow at a substantial CAGR over the forecast period.      

Based on the application, the ferritin testing market is segmented into anaemia, hemochromatosis, lead poisoning, pregnancy, and others. Among these, the anaemia segment accounted for the highest share in 2024 and is projected to grow at a substantial CAGR over the forecast period. Reticulocyte-indexed ferritin evaluation, a more recent diagnostic method that more accurately distinguishes early iron deficiency anaemia by connecting ferritin levels with reticulocyte parameters, is the driving force behind this rise. Because it allows for early diagnosis before haemoglobin drop and encourages proactive treatment choices, this approach is gaining clinical popularity.

 

Regional Segment Analysis of the Ferritin Testing Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

Asia Pacific is anticipated to hold the largest share of the ferritin testing market over the predicted timeframe.     

Asia Pacific is anticipated to hold the largest share of the ferritin testing market over the predicted timeframe. Countries such as India and Indonesia play a large part in the rise of such programs with the introduction of community-based school anaemia programs, utilising ferritin assays for early detection of anaemia for children and adolescents, resulting in a substantial rise in regional demand for tests.

 

Australia has seen a rising ferritin test market due to the increase in home-ferritin testing kits with telehealth links being used by the elderly and remote populations to improve access to testing. Patients collect samples using these kits (the results are electronically uploaded). This improves access to testing, encourages patient compliance, and aids in the early detection of iron-related disorders in rural areas. For instance, the haematological evaluation, or the FeBi test, is a Quantum-Test -developed with the cooperation of First Nation groups across Australia, is working towards creating an innovative alternative to the traditional ferritin test.

 

Europe is projected to grow at a rapid CAGR in the ferritin testing market during the forecast period. The growth of markets in Europe for ferritin assays is expected to continue accelerating as more European nations adopt health and wellness programs for their employees, including Germany and the Netherlands, both of which have begun to integrate routine screening of ferritin as part of their employee health check-ups (EHCs). The focus of these proactive initiatives is to prevent iron deficiency and increase the need for ferritin assays within corporate health care facilities (CHCFs).

 

In Germany, there is a growing need for ferritin tests as a result of the continued increase in hospital-based Geriatric Anaemia Management (GAM) programs being implemented throughout the country, where systematic screening for ferritin will be conducted on all inpatient elderly patients to reduce the risk of complications from iron deficiency. For instance, in December 2023, the London Blood Tests Clinic now offers a comprehensive ferritin blood test, providing fast results (within 1 day) to help patients monitor iron storage levels for conditions such as iron deficiency anaemia and iron overload. The test is available at private clinics in Central London, including Harley Street, with prices starting around £96–£151 depending on the provider.

 

Competitive Analysis:   

The report offers the appropriate analysis of the key organizations/companies involved within the ferritin testing market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

 

List of Key Companies

• Abnova corporation
• Aviva Systems Biology Corporation
• Biomérieux
• Bio-Rad Laboratories
• Cortez Diagnostics Inc
• Cosmic scientific technologies
• Ctk biotech, inc
• Danaher
• Diasys diagnostic systems
• Eurolyser Diagnostica GmbH
• Horiba
• Humankind Ventures Ltd
• Monobind Inc.
• Omega diagnostics
• Others  

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

 

Market Segment  

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the ferritin testing market based on the below-mentioned segments: 

 

Global Ferritin Testing Market, By Product

• Instrument
• Reagent
• Kits
• Others

 

Global Ferritin Testing Market, By Application

• Anemia
• Hemochromatosis
• Lead Poisoning
• Pregnancy
• Others

 

Global Ferritin Testing Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. What is the current size of the Global Ferritin Testing Market?

The market was valued at USD 975.66 million in 2024.

 

2. What is the projected market size by 2035?

It is expected to reach USD 2127.75 million by 2035.

 

3. What is the CAGR during the forecast period?

The market is projected to grow at a CAGR of 7.35% from 2025 to 2035.

 

4. Which region will hold the largest market share?

Asia Pacific is anticipated to hold the largest share over the forecast period.

 

5. Which region is expected to grow the fastest?

Europe is projected to grow at the fastest CAGR during the forecast period.

 

6. What drives growth in the reagent product segment?

Micro-volume ferritin reagent formulations enable high-accuracy testing with minimal blood volumes, ideal for pediatric and geriatric diagnostics.

 

7. Which application segment leads the market?

The anaemia segment accounted for the highest share in 2024 and is expected to grow substantially.

 

8. What are the main market segments by product?

The market is segmented into Instrument, Reagent, Kits, and Others.